Aker BioMarine ASA (OSL:AKBM) Altman Z2-Score: -0.72 (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:AKBM Aker BioMarine ASA OSL:AKBM
64 GF Score
Price kr109.00
GF Value kr74.55
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Aker BioMarine ASA Altman Z2-Score?

Aker BioMarine ASA OSL:AKBM -0.91% 64 Altman Z2-Score is -0.72 as of Aug. 04, 2026. GuruFocus rates OSL:AKBM with a GF Score™ of 64/100 and a GF Value™ of kr74.55 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,941 Consumer Packaged Goods companies, Aker BioMarine ASA ranks worse than 86.76% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Warning Sign:

Aker BioMarine ASA has a Altman Z2-Score of -0.72, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Aker BioMarine ASA's Altman Z2-Score or its related term are showing as below:

OSL:AKBM' s Altman Z2-Score Range Over the Past 10 Years
Min: -0.85   Med: 1.59   Max: 2.07
Current: -0.72

During the past 13 years, Aker BioMarine ASA's highest Altman Z2-Score was 2.07. The lowest was -0.85. And the median was 1.59.


Aker BioMarine ASA  (OSL:AKBM) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Aker BioMarine ASA Altman Z2-Score Related Terms


Aker BioMarine ASA Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Aker BioMarine ASA's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aker BioMarine ASA Altman Z2-Score Chart

Aker BioMarine ASA Annual Data
Trend Dec11 Dec12 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.59 1.94 1.34 -0.37 -0.72

Aker BioMarine ASA Semi-Annual Data
Dec10 Jun11 Dec11 Jun12 Dec12 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.07 -0.37 -0.85 -0.72 0.00

OSL:AKBM vs KHC, GIS, HRL: Altman Z2-Score Comparison

For the Packaged Foods subindustry, Aker BioMarine ASA's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aker BioMarine ASA Altman Z2-Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Aker BioMarine ASA's Altman Z2-Score falls into.


OSL:AKBM
64GF Score
Aker BioMarine ASA OSL:AKBM
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aker BioMarine ASA Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Aker BioMarine ASA's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.3111+3.26*-1.0951+6.72*0.0285+1.05*0.5878
=-0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was kr3,931 Mil.
Total Current Assets was kr2,003 Mil.
Total Current Liabilities was kr780 Mil.
Retained Earnings was kr-4,305 Mil.
Pre-Tax Income was kr-28 Mil.
Interest Expense was kr-140 Mil.
Total Liabilities was kr2,476 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(2003.188 - 780.253)/3930.573
=0.3111

X2=Retained Earnings/Total Assets
=-4304.529/3930.573
=-1.0951

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-28.299 - -140.486)/3930.573
=0.0285

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(1455.394 - 0)/2476.191
=0.5878

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Aker BioMarine ASA has a Altman Z2-Score of -0.72 indicating it is in Distress Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of -0.72 mean?
Aker BioMarine ASA (OSL:AKBM) has a Altman Z2-Score of -0.72 as of Aug. 04, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Aker BioMarine ASA and its competitors. According to the industry distribution chart, Aker BioMarine ASA ranks #1684 out of 1941 companies in the Consumer Packaged Goods industry, placing it in the top 86.8%.
Is Aker BioMarine ASA's Altman Z2-Score too high?
Aker BioMarine ASA's current Altman Z2-Score is -0.72. Based on the distribution chart, Aker BioMarine ASA ranks #1684 out of 1941 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Aker BioMarine ASA has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aker BioMarine ASA's Altman Z2-Score compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Aker BioMarine ASA ranks #1684 out of 1941 companies for Altman Z2-Score. This places Aker BioMarine ASA in the lower half of its industry. The industry median Altman Z2-Score is 3.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Consumer Packaged Goods company?
The median Altman Z2-Score among Consumer Packaged Goods companies is 3.73, based on 1,941 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Aker BioMarine ASA and its competitors. For the Consumer Packaged Goods industry, the median Altman Z2-Score is 3.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aker BioMarine ASA's current Altman Z2-Score is -0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aker BioMarine ASA stock overvalued right now?
Based on GuruFocus' analysis, Aker BioMarine ASA (OSL:AKBM) is currently considered Significantly Overvalued. The stock's GF Value™ is kr74.55, compared to a current price of kr109.00 — trading 46.2% above its estimated fair value. The current Altman Z2-Score is -0.72. Aker BioMarine ASA's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Aker BioMarine ASA (OSL:AKBM), the current Altman Z2-Score is -0.72 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aker BioMarine ASA (OSL:AKBM) Overvalued in 2026?

Based on GuruFocus' analysis, Aker BioMarine ASA stock appears to be overvalued. The current stock price of kr109.00 is trading 46.2% above its estimated GF Value™ of kr74.55. GuruFocus considers Aker BioMarine ASA to be Significantly Overvalued.

Key valuation signals for OSL:AKBM:

  • Altman Z2-Score: -0.72
  • GF Value™: kr74.55 vs. price of kr109.00 (46.2% above fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the OSL:AKBM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aker BioMarine ASA Business Description

Other Exchanges AKBMo:Sweden1PG:Germany
Address Oksenoyveien 10, Lysaker, NOR, 1366
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include Human Health Ingredients, Consumer Health Products, and Emerging Businesses. The company generates the majority of its revenue from the Human Health Ingredients segment, which includes Superba, Lysoveta, PL+ Algae, and the company's Houston manufacturing plant. The segment sells B2B krill oil supplements to nutritional brands for humans around the world.
64GF Score

Get the complete analysis for OSL:AKBM

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr109.00
Price
kr74.55
GF Value